|
You are here:
Education & Tools
>
|
|
 |
 Conference Highlights |
Clinical Mycology
-
SEROTYPES DISTRIBUTION AND DRUG SUSCEPTIBILITIES OF CRYPTOCOCCUS NEOFORMANS AND CANDIDA ALBICANS FROM CLINICAL SOURCES IN NAIROBI, KENYA
Bii CC, Revathi G, Kenya Medical Research Institute,
Nairobi, Kenya
-
TRENDS OF CANDIDEMIA AMONG SURGICAL INTENSIVE CARE UNIT (SICU) PATIENTS
Goff DA, The Ohio State University Medical Center,
Columbus, United States
-
SUPERFICIAL AND CUTANEOUS FUNGAL INFECTIONS IN RENAL TRANSPLANT PATIENTS OF GUATEMALA
Pellecer D, Clinica Familiar, Hospital General San Juan de Dios,
Guatemala City, Guatemala
-
CRYPTOCOCCUS NEOFORMANS INFECTION IN SOLID ORGAN TRANSPLANT (SOT)
Razonable RR, Patel R, Mayo Clinic,
Rochester, United States
-
PATHOGENICITY, HEAVY METAL AND OXIDATIVE STRESS SENSITIVITY OF CANDIDA ALBICANS MORPHOLOGICAL MUTANTS AND THEIR HYBRIDE
Pesti M, Novak A, Emody L, Vagvolgyi C, University of Pecs,
Pecs, Hungary
-
FUNGAL TOENAIL INFECTIONS IN NEUTROPENIC PATIENTS
Elko L, Greene J, Sandin R, Vincent A, University of South Florida,
Miami, United States
-
TOXINOGENICITY OF ASPERGILLUS FUMIGATUS AND A. VERSICOLOR STRAINS ISOLATED FROM PULMONARY ASPERGILLOMA
Pepeljnjak S, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia,
Slobodnjak Z, Thoracic Surgery Unit, University Chest Clinic, Jordanovac, Zagreb, Croatia,
Pavloviæ M, Institute for Medical Research and Occupational Health, Zagreb, Croatia
-
FUNGAL INFECTIONS AS AN IMPORTANT CAUSE OF SEVERE SEPSIS
Gaber G, Ottawa Hospital, Ottawa, Canada,
Opal SM, Brown University, Providence, United States,
Larosa SP, Cleveland Clinic, Cleveland, United States,
Maki DG, University of Wisconsin, Madison, United States
-
A COMPARISON OF CLINICAL SYMPTOMS OF PNEUMOCYSTIS CARINII PNEUMONIA BETWEEN HIV AND NON-HIV PATIENTS
Kasahara K, Takahashi K, Konishi M, Uno K, Yoshimoto E,
Murakawa K, Maeda K, Mikasa K, Kimura H, Kita E, Nara
Medical University,
Kashihara-City, Japan
-
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH A HISTORY OF PRIOR INVASIVE ASPERGILLOSIS: OUTCOMES AND RISKS FOR POST-TRANSPLANT INVASIVE ASPERGILLOSIS
Fukuda T, Owens SM, Boeckh M, Guthrie KA, Mattson DK, Wald
A, Corey L, Storb RF, Marr KA, Fred Hutchinson Cancer
Research Center,
Seattle, United States
-
INVASIVE FUNGAL INFECTIONS IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER NONMYELOABLATIVE CONDITIONING: RISKS AND OUTCOMES
Fukuda T, Boeckh M, Carter RA, Sandmaier BM, Maris MB,
Maloney DG, Martin PJ, Storb RF, Marr KA, Fred Hutchinson
Cancer Research Center,
Seattle, United States
-
CLINICAL PREDICTIVE MODELING IN CHILDREN
Benjamin D, DeLong E, Duke University Clinical Research, Durham, United States,
Steinbach W, Cotten C, Duke University Pediatrics, Durham, United States,
Walsh T, National Cancer Institute, Bethesda, MD, United States Durham, United States,
Clark R, Pediatrix Medical Group, Inc.
-
PHARMACOECONOMICS OF PROPHYLAXIS OF FUNGAL INFECTIONS IN PATIENTS UNDERGOING A HEMATOPOIETIC STEM CELL TRANSPLANT
Prendergast MM, Tong KB, Fujisawa Healthcare, Inc.,
Deerfield, United States
-
FAILURE OF TREATMENT OF CRYPTOCOCCOSIS IN A NONHIV INFECTED PATIENT
Nguyen HH, Avante CJ, Siddiqui J, King J, Cohen SH, University of California, Davis,
Sacramento, United States
-
IS THE STANDARD DOSE OF SULFAMETHOXAZOLE / TRIMETHOPRIM ADEQUATE IN PATIENTS WITH AIDS-RELATED PNEUMOCYSTIS CARINII PNEUMONIA?
Konishi M, Yoshimoto E, Takahashi K, Uno K, Kasahara K, Murakawa K, Maeda K, Mikasa K, Nara Medical University,
Nara, Japan
-
COMPARATIVE NEPHROTOXICITY, ADVERSE EVENTS, AND CLINICAL OUTCOMES WITH LIPID-ASSOCIATED AMPHOTERICIN B PRODUCTS
Couch K, Christiana Care Health System, Newark, United
States, Chan S, Cincotta E, University of Maryland Medical Center, Baltimore, United States,
Piper JP, Christiana Care Health System, Newark, United States,
Forrest G, University of Maryland Medical Center, Baltimore, United States
-
A MULTI-CENTER, RETROSPECTIVE COMPARISON OF THE NEPHROTOXIC EFFECTS OF AMPHOTERICIN B LIPID COMPLEX AND LIPOSOMAL AMPHOTERICIN B
McKechnie M, Rotstein C, McTaggart B, Hamilton Health Sciences,
Hamilton, Canada
-
INCIDENCE AND CONSEQUENCES OF NEPHROTOXICITY IN HSCT TREATED WITH EMPIRIC AMPHOTERICIN, MICAFUNGIN OR NO ANTI-FUNGAL AGENT
Drajer D, Frame D, Kemper M, Weinstein A, RUSH Medical Center,
Chicago, United States
-
IN VITRO AND IN VIVO HUMAN METABOLISM OF ALBACONAZOLE
Nadal T, Carbo M, Izquierdo I, De La Cruz G, Bartroli J, Merlos M, R & D Center,
Barcelona, Spain
-
SAFETY AND PRELIMINARY PHARMACOKINETICS OF AN ORAL SOLUTION CONTAINING ALBACONAZOLE AFTER SINGLE AND MULTIPLE DOSE ADMINISTRATION TO HEALTHY VOLUNTEERS
De La Cruz G, Rigau D, Nadal T, Carbo M, Lurigados C, Bartroli J, Zguierdo I, R & D Center,
Barcelona, Spain
|
|